Alk-positive anaplastic large cell lymphoma Clinical Trials
Conditions / Alk-positive anaplastic large cell lymphoma
Delta Trials records 6 clinical trials for Alk-positive anaplastic large cell lymphoma in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 22 study locations around the world. An additional 5 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
6
Total Trials
0
Recruiting
1
Completed
5
Other Active
0
Terminated since 2020
22
Study Locations
Browse by location (22 total)
- Guangzhou, China 4 trialsAll trials in Guangzhou, China
- Zhengzhou, China 2 trialsAll trials in Zhengzhou, China
- Terni, Italy 1 trialAll trials in Terni, Italy
- Vancouver, Canada 1 trialAll trials in Vancouver, Canada
- Hangzhou, China 1 trialAll trials in Hangzhou, China
- Bologna, Italy 1 trialAll trials in Bologna, Italy
- Shanghai, China 1 trialAll trials in Shanghai, China
- Beijing, China 1 trialAll trials in Beijing, China
- Pisa, Italy 1 trialAll trials in Pisa, Italy
- Pierrebenite, France 1 trialAll trials in Pierrebenite, France
- Harbin, China 1 trialAll trials in Harbin, China
- Taipei, Taiwan 1 trialAll trials in Taipei, Taiwan
- Taipei, Taiwan 1 trialAll trials in Taipei, Taiwan
- Caen, France 1 trialAll trials in Caen, France
- Chengdu, China 1 trialAll trials in Chengdu, China
- Parma, Italy 1 trialAll trials in Parma, Italy
- Genova, Italy 1 trialAll trials in Genova, Italy
- Toulouse, France 1 trialAll trials in Toulouse, France
- Bergamo, Italy 1 trialAll trials in Bergamo, Italy
- Xuzhou, China 1 trialAll trials in Xuzhou, China